Roth, Mary E <br/><br/>
Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma.  [electronic resource] 

 -  American journal of therapeutics   
 - e1925-e1928 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1536-3686 
<br/><br/><label>Standard No.: </label>10.1097/MJT.0000000000000430  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Atrial Fibrillation--chemically induced<br/>Bundle-Branch Block--complications<br/>Humans<br/>Hypertension--complications<br/>Ipilimumab<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Skin Neoplasms--pathology<br/>Stroke Volume<br/>Ventricular Dysfunction, Left--chemically induced